Emmes, a full-service Clinical Research Organization (CRO) dedicated to supporting biopharmaceutical innovation, will open a new office in Wilmington, North Carolina. The official launch of the new hub will be on February 22.

With the addition of the new facility, Emmes will employee a dozen people in the greater Wilmington area.

“Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area,” said Christine Dingivan, Emmes CEO.  “We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.

Rhonda Henry, president of Emmes BioPharma said: “My roots are deep here, and that makes me even more excited about this expansion. The new base in Wilmington will allow us to draw from the deep clinical research talent pool in the area, which includes seasoned professionals as well as new graduates from UNC Wilmington’s undergraduate and graduate clinical research programs.”

Henry added: “With our focus on collaboration, flexibility and innovation, Emmes is a different kind of CRO. Our continued growth offers opportunities for others to join us and see their careers flourish.”

Wendy Buckland, chief operating officer, and the newest member of the Emmes executive team, said: “We’ve extended our view of innovation to the workspace itself,” she added, “calling it a collaboration hub instead of a typical office. It is modern, open and informal – a collegial gathering place versus a traditional office where employees are required to come in daily.”

The company’s acquisition of five companies since December 2020, has expanded its reach from the U.S., Canada and India to countries throughout Europe and the United Kingdom. With the Wilmington hub, Emmes now has 19 offices in strategic locations throughout the world.